Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cancer Immunotherapy Drug Discovery Outsourcing market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Immunotherapy Drug Discovery Outsourcingmarket, defines the market attractiveness level of Cancer Immunotherapy Drug Discovery Outsourcing market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Immunotherapy Drug Discovery Outsourcing industry, describes the types of Cancer Immunotherapy Drug Discovery Outsourcing market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Immunotherapy Drug Discovery Outsourcing market and the development prospects and opportunities of Cancer Immunotherapy Drug Discovery Outsourcing industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Immunotherapy Drug Discovery Outsourcing market in Chapter 13.
By Player:
ImmunXperts SA
Genscript Biotech Corporation
Crown Bioscience, Inc
Horizon Discovery Group PLC
Molecular Imaging, Inc
HD Biosciences Co, Ltd
Explicyte
DiscoverX Corporation
STC Biologics
BPS Bioscience, Inc
Celentyx Ltd
Personalis, Inc
Aquila BioMedical
Covance, Inc
Promega Corporation
By Type:
Monoclonal Antibodies
Immunomodulators
Oncolytic Viral Therapies and Cancer Vaccines
Other
By End-User:
Lung
Breast
Colorectal
Melanoma
Prostate
Head and Neck
Ovarian
Pancreatic
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Immunotherapy Drug Discovery Outsourcing Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Immunotherapy Drug Discovery Outsourcing Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Immunotherapy Drug Discovery Outsourcing Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis and Outlook to 2022
-
7.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Consumption (2017-2022)
-
7.2 United States Cancer Immunotherapy Drug Discovery Outsourcing Consumption (2017-2022)
-
7.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption (2017-2022)
-
7.4 China Cancer Immunotherapy Drug Discovery Outsourcing Consumption (2017-2022)
-
7.5 Japan Cancer Immunotherapy Drug Discovery Outsourcing Consumption (2017-2022)
-
7.6 India Cancer Immunotherapy Drug Discovery Outsourcing Consumption (2017-2022)
-
7.7 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Consumption (2017-2022)
8 Region and Country-wise Cancer Immunotherapy Drug Discovery Outsourcing Market Analysis and Outlook to 2028
-
8.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast (2022-2028)
-
8.2 United States Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast (2022-2028)
-
8.4 China Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast (2022-2028)
-
8.6 India Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast (2022-2028)
9 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immunomodulators Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Oncolytic Viral Therapies and Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Lung Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Breast Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Colorectal Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Melanoma Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Prostate Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Head and Neck Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Ovarian Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Pancreatic Consumption and Growth Rate (2017-2022)
10 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immunomodulators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Oncolytic Viral Therapies and Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Lung Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Breast Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Colorectal Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Prostate Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Head and Neck Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Ovarian Consumption Forecast and Growth Rate (2022-2028)
-
10.2.8 Global Pancreatic Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Immunotherapy Drug Discovery Outsourcing Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Analysis
-
14.1 ImmunXperts SA
-
14.1.1 ImmunXperts SA Company Details
-
14.1.2 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
14.2 Genscript Biotech Corporation
-
14.2.1 Genscript Biotech Corporation Company Details
-
14.2.2 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
14.3 Crown Bioscience, Inc
-
14.3.1 Crown Bioscience, Inc Company Details
-
14.3.2 Crown Bioscience, Inc Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Crown Bioscience, Inc Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
14.4 Horizon Discovery Group PLC
-
14.4.1 Horizon Discovery Group PLC Company Details
-
14.4.2 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
14.5 Molecular Imaging, Inc
-
14.5.1 Molecular Imaging, Inc Company Details
-
14.5.2 Molecular Imaging, Inc Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Molecular Imaging, Inc Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
14.6 HD Biosciences Co, Ltd
-
14.6.1 HD Biosciences Co, Ltd Company Details
-
14.6.2 HD Biosciences Co, Ltd Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 HD Biosciences Co, Ltd Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
14.7 Explicyte
-
14.7.1 Explicyte Company Details
-
14.7.2 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
14.8 DiscoverX Corporation
-
14.8.1 DiscoverX Corporation Company Details
-
14.8.2 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
14.9 STC Biologics
-
14.9.1 STC Biologics Company Details
-
14.9.2 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
14.10 BPS Bioscience, Inc
-
14.10.1 BPS Bioscience, Inc Company Details
-
14.10.2 BPS Bioscience, Inc Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 BPS Bioscience, Inc Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
14.11 Celentyx Ltd
-
14.11.1 Celentyx Ltd Company Details
-
14.11.2 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
14.12 Personalis, Inc
-
14.12.1 Personalis, Inc Company Details
-
14.12.2 Personalis, Inc Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Personalis, Inc Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
14.13 Aquila BioMedical
-
14.13.1 Aquila BioMedical Company Details
-
14.13.2 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
14.14 Covance, Inc
-
14.14.1 Covance, Inc Company Details
-
14.14.2 Covance, Inc Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Covance, Inc Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
14.15 Promega Corporation
-
14.15.1 Promega Corporation Company Details
-
14.15.2 Promega Corporation Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Promega Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Immunotherapy Drug Discovery Outsourcing
-
Figure Cancer Immunotherapy Drug Discovery Outsourcing Picture
-
Table Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Consumption by Country (2017-2022)
-
Figure United States Cancer Immunotherapy Drug Discovery Outsourcing Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Immunotherapy Drug Discovery Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Immunotherapy Drug Discovery Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Immunotherapy Drug Discovery Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Immunotherapy Drug Discovery Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Immunotherapy Drug Discovery Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Immunomodulators Consumption and Growth Rate (2017-2022)
-
Figure Global Oncolytic Viral Therapies and Cancer Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Consumption and Growth Rate (2017-2022)
-
Figure Global Colorectal Consumption and Growth Rate (2017-2022)
-
Figure Global Melanoma Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Consumption and Growth Rate (2017-2022)
-
Figure Global Head and Neck Consumption and Growth Rate (2017-2022)
-
Figure Global Ovarian Consumption and Growth Rate (2017-2022)
-
Figure Global Pancreatic Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunomodulators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncolytic Viral Therapies and Cancer Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colorectal Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Melanoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Head and Neck Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ovarian Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pancreatic Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Immunotherapy Drug Discovery Outsourcing Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Immunotherapy Drug Discovery Outsourcing Export by Region (Top 5 Countries) (2017-2028)
-
Table ImmunXperts SA (Foundation Year, Company Profile and etc.)
-
Table ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
Table Genscript Biotech Corporation (Foundation Year, Company Profile and etc.)
-
Table Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
Table Crown Bioscience, Inc (Foundation Year, Company Profile and etc.)
-
Table Crown Bioscience, Inc Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Crown Bioscience, Inc Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
Table Horizon Discovery Group PLC (Foundation Year, Company Profile and etc.)
-
Table Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
Table Molecular Imaging, Inc (Foundation Year, Company Profile and etc.)
-
Table Molecular Imaging, Inc Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Molecular Imaging, Inc Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
Table HD Biosciences Co, Ltd (Foundation Year, Company Profile and etc.)
-
Table HD Biosciences Co, Ltd Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table HD Biosciences Co, Ltd Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
Table Explicyte (Foundation Year, Company Profile and etc.)
-
Table Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
Table DiscoverX Corporation (Foundation Year, Company Profile and etc.)
-
Table DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
Table STC Biologics (Foundation Year, Company Profile and etc.)
-
Table STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
Table BPS Bioscience, Inc (Foundation Year, Company Profile and etc.)
-
Table BPS Bioscience, Inc Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table BPS Bioscience, Inc Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
Table Celentyx Ltd (Foundation Year, Company Profile and etc.)
-
Table Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
Table Personalis, Inc (Foundation Year, Company Profile and etc.)
-
Table Personalis, Inc Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Personalis, Inc Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
Table Aquila BioMedical (Foundation Year, Company Profile and etc.)
-
Table Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
Table Covance, Inc (Foundation Year, Company Profile and etc.)
-
Table Covance, Inc Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Covance, Inc Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
Table Promega Corporation (Foundation Year, Company Profile and etc.)
-
Table Promega Corporation Cancer Immunotherapy Drug Discovery Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Promega Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product and Service
-
